Elevance Health Insiders Sell US$9.2m Of Stock, Possibly Signalling Caution
Elevance Health Insiders Sell US$9.2m Of Stock, Possibly Signalling Caution
The fact that multiple Elevance Health, Inc. (NYSE:ELV) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, if numerous insiders are selling, shareholders should investigate more.
在过去的一年中,多个Elevance Health, Inc. (纽交所:ELV) 内部人士卖出了大量股份,这可能引起投资者的注意。了解内部人员是否购买股票通常在评估内部交易时更有帮助,因为内部人员的出售可能有各种解释。然而,如果有多个内部人士卖出股份,股东应该进行更深入的调查。
While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.
虽然在长期投资中,内部交易并不是最重要的事情,但我们认为关注内部人士的行动是非常合理的。
The Last 12 Months Of Insider Transactions At Elevance Health
Elevance Health内部交易的过去12个月
In the last twelve months, the biggest single sale by an insider was when the Executive VP & President of Government Health Benefits, Felicia Norwood, sold US$6.8m worth of shares at a price of US$535 per share. That means that even when the share price was slightly below the current price of US$535, an insider wanted to cash in some shares. We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. We note that the biggest single sale was only 36% of Felicia Norwood's holding.
在过去的12个月中,公司高级副总裁兼政府健康福利总裁Felicia Norwood进行的最大单笔销售是以每股535美元的价格出售了价值680万美元的股票。这意味着即使股价略低于目前的535美元,内部人员也想现金化一些股份。我们通常认为如果内部人员一直在卖出股票,特别是如果他们以低于目前价值的价格卖出股票,这是一个负面信号,因为这意味着他们认为更低的价格是合理的。虽然内部人员出售股票并不是一个积极的信号,但我们不能确定这是否意味着内部人员认为股票已经被充分估值,因此这只是一个薄弱的信号。我们注意到最大的单笔销售只占Felicia Norwood持股的36%。
Insiders in Elevance Health didn't buy any shares in the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
Elevance Health内部人员在过去一年中没有购买任何股票。以下是内部交易(按公司和个人)在过去12个月中的可视化描述。如果您单击图表,您可以查看所有的单独交易,包括股价、个人和日期!
![insider-trading-volume](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240626/0-c748c45e75e3389d821866a29941a8dc-0-7502d67ad57b9ef4061b74c3997f5092.png/big)
If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).
如果你喜欢购买内部人员正在购买而不是销售的股票,那么你可能会喜欢这份免费的公司列表。(提示:它们中的大部分都被忽视了。)
Elevance Health Insiders Are Selling The Stock
Elevance Health内部人员正在抛售股票
The last quarter saw substantial insider selling of Elevance Health shares. Specifically, Executive VP & President of Government Health Benefits Felicia Norwood ditched US$6.8m worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain.
前一个季度Elevance Health 出现了大量的内部股票抛售。具体而言,公司高级副总裁兼政府健康福利总裁Felicia Norwood在此期间卖出了价值680万美元的股票,我们没有记录任何购买记录。考虑到这一点,很难否认所有内部人员认为股票是便宜的。
Does Elevance Health Boast High Insider Ownership?
Elevance Health是否拥有高内部股权?
For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Elevance Health insiders own 0.1% of the company, currently worth about US$176m based on the recent share price. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
对于普通股东而言,值得检查公司内部人员持有多少股份。如果内部人员在公司拥有大量股份,我认为这是一个好的信号。Elevance Health内部人员目前拥有该公司0.1%的股份,价值约1.76亿美元。我喜欢看到这种水平的内部股权,因为这增加了管理层考虑股东最佳利益的机会。
So What Do The Elevance Health Insider Transactions Indicate?
Elevance Health内部交易是什么意思?
An insider sold Elevance Health shares recently, but they didn't buy any. Looking to the last twelve months, our data doesn't show any insider buying. But it is good to see that Elevance Health is growing earnings. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of Elevance Health.
内部人员最近出售了Elevance Health股票,但他们没有购买任何股票。在过去的十二个月中,我们的数据没有显示任何内部购买行为。但很高兴看到Elevance Health有盈利增长。尽管内部人员确实拥有公司的许多股份(这是好事),但对于公司的交易,我们的分析并没有让我们对该公司感到自信。这些内部交易可以帮助我们建立有关股票的论点,但了解面临的风险也是有价值的。为了协助您了解这一点,我们发现了1个警告信号,您应该仔细观察以获得关于Elevance Health的更全面的图片。
But note: Elevance Health may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
但是请注意:Elevance Health可能不是最好的买入股票。因此,请查看高ROE和低债务的有趣公司免费列表。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
对于本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置,但不包括衍生交易或间接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈?关于内容有所顾虑?直接和我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
对本文有反馈?关于内容有所顾虑?直接和我们联系。或者发送电子邮件至editorial-team@simplywallst.com。